Literature DB >> 19559738

Generation of Tioman virus nucleocapsid-like particles in yeast Saccharomyces cerevisiae.

Rasa Petraityte1, Paulius L Tamosiunas, Mindaugas Juozapaitis, Aurelija Zvirbliene, Kestutis Sasnauskas, Brian Shiell, Gail Russell, John Bingham, Wojtek P Michalski.   

Abstract

Tioman virus (TioV) was isolated from a number of pooled urine samples of Tioman Island flying foxes (Pteropus hypomelanus) during the search for the reservoir host of Nipah virus. Studies have established TioV as a new virus in the family Paramyxoviridae. This novel paramyxovirus is antigenically related to Menangle virus that was isolated in Australia in 1997 during disease outbreak in pigs. TioV causes mild disease in pigs and has a predilection for lymphoid tissues. Recent serosurvey showed that 1.8% of Tioman Islanders had neutralizing antibodies against TioV, indicating probable past infection. For the development of convenient serological tests for this virus, recombinant TioV nucleocapsid (N) protein was expressed in the yeast Saccharomyces cerevisiae. High yields of recombinant TioV N protein were obtained. Electron microscopy demonstrated that purified recombinant N protein self-assembled into nucleocapsid-like particles which were identical in density and morphology to authentic nucleocapsids from paramyxovirus-infected cells. Different size nucleocapsid-like particles were stable and readily purified by CsCl gradient ultracentrifugation. Polyclonal sera raised in rabbits after immunization with recombinant TioV N protein reacted reliably with TioV infected tissues in immunohistochemistry tests. It confirmed that the antigenic properties of yeast derived TioV N protein are identical to authentic viral protein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559738     DOI: 10.1016/j.virusres.2009.06.013

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  5 in total

1.  Phylogenetic analysis of Puumala virus subtype Bavaria, characterization and diagnostic use of its recombinant nucleocapsid protein.

Authors:  Marc Mertens; Eveline Kindler; Petra Emmerich; Jutta Esser; Christiane Wagner-Wiening; Roman Wölfel; Rasa Petraityte-Burneikiene; Jonas Schmidt-Chanasit; Aurelija Zvirbliene; Martin H Groschup; Gerhard Dobler; Martin Pfeffer; Gerald Heckel; Rainer G Ulrich; Sandra S Essbauer
Journal:  Virus Genes       Date:  2011-05-20       Impact factor: 2.332

2.  Serological evidence of a pararubulavirus and a betacoronavirus in the geographically isolated Christmas Island flying-fox (Pteropus natalis).

Authors:  Laura A Pulscher; Alison J Peel; Karrie Rose; Justin A Welbergen; Michelle L Baker; Victoria Boyd; Samantha Low-Choy; Dan Edson; Christopher Todd; Annabel Dorrestein; Jane Hall; Shawn Todd; Christopher C Broder; Lianying Yan; Kai Xu; Grantley R Peck; David N Phalen
Journal:  Transbound Emerg Dis       Date:  2022-05-11       Impact factor: 4.521

3.  Purification and characterisation of immunoglobulins from the Australian black flying fox (Pteropus alecto) using anti-fab affinity chromatography reveals the low abundance of IgA.

Authors:  James W Wynne; Antonio Di Rubbo; Brian J Shiell; Gary Beddome; Christopher Cowled; Grantley R Peck; Jing Huang; Samantha L Grimley; Michelle L Baker; Wojtek P Michalski
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

4.  Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.

Authors:  Juozas Nainys; Rita Lasickiene; Rasa Petraityte-Burneikiene; Jonas Dabrisius; Raimundas Lelesius; Vilimas Sereika; Aurelija Zvirbliene; Kestutis Sasnauskas; Alma Gedvilaite
Journal:  BMC Biotechnol       Date:  2014-12-09       Impact factor: 2.563

Review 5.  Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems.

Authors:  Zeinab Shirbaghaee; Azam Bolhassani
Journal:  Biopolymers       Date:  2016-03       Impact factor: 2.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.